{"product_id":"dischem-pestle-analysis","title":"Dis-Chem PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, consumer health trends, and tech-driven retailing shape Dis-Chem’s future in our concise PESTLE snapshot—designed to inform investment and strategy decisions quickly. Buy the full PESTLE analysis for a detailed, actionable breakdown of regulatory risks, economic pressures, and environmental trends that could impact margins and growth. Download now to get ready-to-use insights for reports, pitches, or strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNational Health Insurance implementation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe South African government's NHI progress creates uncertainty for private pharmacies; NHI pilot phases cover 10 of 52 health districts and the 2024 White Paper targets phased implementation by 2030, risking changes to dispensing rights and reimbursement for Dis-Chem.\u003c\/p\u003e\n\u003cp\u003eDis-Chem must prepare for centralized procurement—South Africa spent R218 billion on medicines in 2023—potentially compressing margins and altering supplier relationships.\u003c\/p\u003e\n\u003cp\u003eScaling its 400+ clinic network and positioning as a primary healthcare provider is essential for Dis-Chem to secure patient flow and revenue under a hybrid public-private model.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolitical stability and governance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOngoing political shifts and the Government of National Unity’s performance affect investor confidence; South Africa’s political risk premium rose to 2.1 percentage points in 2024, weighing on retail investment decisions. Legislative efficacy and policy rollout for trade and healthcare—key to pharmacy regulation—have slowed, with 2024 health budget growth at 3.8% vs. a 5-year average of 6.1%. Dis-Chem must model for policy volatility and possible ministerial reprioritisation impacting licensing and reimbursements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eB-BBEE compliance and transformation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eB-BBEE remains a regulatory imperative in South Africa; Dis-Chem, which reported a 2024 empowerment scorecard showing level 4 compliance and 25% black ownership in its 2023 annual report, must sustain improvements to secure government tenders and retain its social license.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational trade and import policies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical decisions on import duties and trade agreements directly affect Dis-Chem’s cost base for internationally sourced health and beauty products; for example, South Africa’s average applied tariff on cosmetics is 7.1% (WTO 2023), raising input costs if preferential access changes.\u003c\/p\u003e\n\u003cp\u003eEscalating trade tensions can trigger supply-chain disruptions or higher tariffs on specialized supplements and luxury cosmetics, potentially widening gross margins by several percentage points if costs are passed on.\u003c\/p\u003e\n\u003cp\u003eMaintaining a diversified supplier base across regions mitigates risks from shifting geopolitical alliances; Dis-Chem’s 2024 supplier diversification reduced single-country sourcing exposure to under 20%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAverage cosmetics tariff SA 7.1% (WTO 2023)\u003c\/li\u003e\n\u003cli\u003eTrade shocks can move gross margins by multiple percentage points\u003c\/li\u003e\n\u003cli\u003e2024: single-country supplier exposure \u0026lt;20%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health policy and vaccine mandates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment vaccination drives position Dis-Chem as a frontline implementer; during 2024 the chain delivered over 1.2 million state-funded vaccines and vaccines\/medications accounted for an estimated 8% of retail revenue.\u003c\/p\u003e\n\u003cp\u003eDis-Chem's role in distributing Department of Health-supplied medicines requires strict compliance to avoid fines and service interruptions; national mandates boosted in-store clinic visits by ~18% in 2023–24.\u003c\/p\u003e\n\u003cp\u003eAlignment with health directives supports public wellness targets and preserves access to R1.4 billion in public procurement contracts awarded to major pharmacy chains in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDelivered \u0026gt;1.2M state-funded vaccines (2024)\u003c\/li\u003e\n\u003cli\u003eVaccines\/meds ≈ 8% of retail revenue\u003c\/li\u003e\n\u003cli\u003eIn-store clinic visits +18% (2023–24)\u003c\/li\u003e\n\u003cli\u003ePublic procurement ~R1.4bn (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy shake-up: NHI, centralized procurement and higher SA risk premium hit pharma\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks: NHI rollout (phased to 2030) threatens dispensing\/reimbursement; R218bn medicine spend (2023) implies centralized procurement pressure; political\/policy volatility raised SA risk premium to 2.1ppt (2024); B-BBEE level 4, 25% black ownership (2023) required for tenders; delivered \u0026gt;1.2M state vaccines (2024), public procurement ~R1.4bn.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicine spend 2023\u003c\/td\u003e\n\u003ctd\u003eR218bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRisk premium 2024\u003c\/td\u003e\n\u003ctd\u003e2.1 ppt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eState vaccines 2024\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic procurement 2024\u003c\/td\u003e\n\u003ctd\u003eR1.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental factors uniquely affect Dis-Chem across Political, Economic, Social, Technological, Environmental and Legal dimensions, with data-driven subpoints and forward-looking insights tailored to the South African retail pharmacy context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Dis-Chem's PESTLE into a sharp, shareable summary for meetings or presentations, visually segmented by category and written in plain language so teams can quickly align on external risks and market positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer disposable income pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePersistent inflation (CPI ~5.9% in 2025) and policy rates near 8.25% have eroded South African household real incomes, prompting tighter spending; Dis-Chem benefits from non-discretionary pharma sales but its luxury beauty and nutrition lines face demand risk. In FY2024 Dis-Chem reported gross margin pressure and increased promotional activity; the firm must balance premium assortments with growth in value-focused house brands to retain price-sensitive shoppers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency volatility and exchange rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuations of the rand—down ~6% vs USD in 2024 and volatility with average monthly FX swings of 3–4%—raise landing costs for Dis-Chem’s imported health products, squeezing gross margins when the ZAR depreciates. As a major importer of specialized pharmaceuticals and equipment, Dis-Chem saw imported cost inflation contribute to a 1.2–1.8ppt reduction in gross margin in parts of 2023–24. Hedging programs and increased local sourcing (targeting 15–20% more locally procured SKUs by 2025) are used to stabilize retail pricing and protect margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnemployment and market growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh structural unemployment in South Africa (32.9% Q4 2025 expanded definition) constrains the addressable market for private healthcare and retail pharmacy services, limiting Dis-Chem’s premium customer base.\u003c\/p\u003e\n\u003cp\u003eEconomic stagnation and subdued real GDP growth (0.6% 2024, IMF est. 0.8% 2025) hinder middle-class expansion, reducing demand for Dis-Chem’s high-margin wellness products.\u003c\/p\u003e\n\u003cp\u003eTo sustain volume and revenue, Dis-Chem may need to pursue lower-income segments via smaller-format stores and value ranges, mirroring competitors that target price-sensitive consumers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnergy costs and load shedding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOperating large Dis-Chem stores and temperature-controlled warehouses drives high energy use; South African retail electricity tariff increases averaged about 12%–15% annually in 2023–2024, pressuring margins.\u003c\/p\u003e\n\u003cp\u003eBackup generator fuel and maintenance raised operating costs—Dis-Chem noted energy and utilities exposure in 2024 financials, with energy-related expenses materially impacting store-level EBITDA.\u003c\/p\u003e\n\u003cp\u003eInvestment in on-site solar or efficiency reduced volatility risk but requires capex; efficient energy management is essential to preserve profitability amid load-shedding.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 tariffs +12%–15%\u003c\/li\u003e\n\u003cli\u003eBackup generator \u0026amp; fuel add significant variable costs\u003c\/li\u003e\n\u003cli\u003eOn-site solar capex offsets long-term volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSingle Exit Price (SEP) regulations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe South African Single Exit Price caps pharmacy margins on scheduled medicines, constraining Dis-Chem’s profitability from prescriptions; SEP rose about 3.4% in 2024 versus CPI of ~5.9%, squeezing retail pharmacy gross margins.\u003c\/p\u003e\n\u003cp\u003eConsequently Dis-Chem emphasizes high-volume front-shop goods and clinic\/optometry services—these non-SEP revenues made up over 45% of group sales in FY2024—to offset limited drug margin growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSEP growth 2024 ~3.4% vs CPI ~5.9%\u003c\/li\u003e\n\u003cli\u003eNon-SEP sales \u0026gt;45% of FY2024 revenue\u003c\/li\u003e\n\u003cli\u003ePharmacy margins pressured, reliant on volume and services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost pressures squeeze margins as weak growth, high rates and energy hikes bite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInflation ~5.9% (2025), policy rate 8.25%, rand down ~6% vs USD (2024) squeeze margins; SEP +3.4% (2024) limits pharmacy margins so non-SEP sales \u0026gt;45% of FY2024 revenue; unemployment ~32.9% (Q4 2025) and GDP ~0.6% (2024) constrain premium demand; energy tariffs +12–15% (2023–24) and backup fuel raise operating costs, driving capex for solar.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInflation (CPI)\u003c\/td\u003e\n\u003ctd\u003e~5.9% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolicy rate\u003c\/td\u003e\n\u003ctd\u003e8.25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRand vs USD\u003c\/td\u003e\n\u003ctd\u003e-6% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSEP increase\u003c\/td\u003e\n\u003ctd\u003e+3.4% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-SEP share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;45% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnemployment\u003c\/td\u003e\n\u003ctd\u003e32.9% Q4 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGDP growth\u003c\/td\u003e\n\u003ctd\u003e0.6% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnergy tariffs\u003c\/td\u003e\n\u003ctd\u003e+12–15% (2023–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eDis-Chem PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Dis-Chem PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use with no placeholders or surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751625732473,"sku":"dischem-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/dischem-pestle-analysis.png?v=1772233552","url":"https:\/\/growthsharematrix.com\/products\/dischem-pestle-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}